You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

triple negative breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunotherapy-related CRP Kinetics in Early and Metastatic

Recruiting
  • TNBC - Triple-Negative Breast Cancer
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Proleukin 1.3 MG Injection
    • (no location specified)
    Apr 6, 2023

    Looking At Triple Negative Breast Cancer Patient Experience

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Breast Cancer
      • (no location specified)
      Mar 3, 2023

      Triple Negative Breast Cancer, Neoadjuvant Chemo, Pembrolizumab Trial in Seoul (Visium, Whole Genome Sequencing(WGS)/Whole

      Recruiting
      • Triple Negative Breast Cancer
      • +3 more
      • Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS)
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 15, 2023

      Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • Xiaopi granules
      • +2 more
      • (no location specified)
      Nov 22, 2023

      TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

      Recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Wuhan, Hubei, China
        Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
      Nov 5, 2023

      Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

      Not yet recruiting
      • Metastatic Triple-Negative Breast Cancer
      • Charlotte, North Carolina
        Levine Cancer Institute
      Aug 31, 2023

      Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Dhaka, Bangladesh
        Bangabandhu Sheikh Mujib Medical University
      May 24, 2023

      Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)

      Recruiting
      • Breast Cancer
      • 99mTc-MY6349 SPECT/CT scan
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Oct 24, 2023

      TNBC - Triple-Negative Breast Cancer Trial in Brussels (Ga-PSMA PET/CT)

      Recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Ga-PSMA PET/CT
      • Brussels, Belgium
        Institut Jules Bordet
      Sep 26, 2023

      Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • Pembrolizumab injection
      • +2 more
      • (no location specified)
      Jul 25, 2023

      Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

      Not yet recruiting
      • Triple Negative Breast Cancer
      • +2 more
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 25, 2023

      TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

      Not yet recruiting
      • TNBC - Triple-Negative Breast Cancer
      • Camrelizumab Plus Chemotherapy and Famitinib
      • Camrelizumab Plus Chemotherapy
      • (no location specified)
      Aug 17, 2023

      Checkpoint Inhibitors in Triple Negative Breast

      Recruiting
      • Triple Negative Breast Cancer
      • Whole Genome Sequencing
      • +7 more
      • Barcelona, Spain
        Vall d'Hebron Institute of Oncology
      Jun 20, 2023

      Breast Cancer, Triple Negative Breast Cancer Trial in Gothenburg (Imatinib 400 MG Oral Tablet)

      Not yet recruiting
      • Breast Cancer
      • Triple Negative Breast Cancer
      • Imatinib 400 MG Oral Tablet
      • Gothenburg, Sweden
        Barbro Linderholm
      Feb 1, 2023

      Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • Atezolizumab + RP1
      • Paris, France
        Institut Curie
      Oct 2, 2023

      Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (proton plus carbon ion radiotherapy)

      Recruiting
      • Triple Negative Breast Cancer
      • HER2-positive Breast Cancer
      • proton plus carbon ion radiotherapy
      • Shanghai, China
        Shanghai Proton and Heavy Ion center
      Jan 11, 2023

      Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

      Not yet recruiting
      • Breast Cancer Triple Negative
      • +3 more
        • Atlanta, Georgia
          Emory University/Winship Cancer Institute
        May 18, 2023

        TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • Alkaline Glucosodiene Molecules
        • (no location specified)
        Jul 14, 2023

        Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

        Not yet recruiting
        • Breast Cancer
        • Triple Negative Breast Cancer
        • (no location specified)
        Jun 11, 2023

        Advanced Triple Negative Breast Cancer Trial in Shantou (SZ011 CAR-NK)

        Not yet recruiting
        • Advanced Triple Negative Breast Cancer
        • SZ011 CAR-NK
        • Shantou, China
          Shantou
        Jan 9, 2023

        TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

        Not yet recruiting
        • TNBC - Triple-Negative Breast Cancer
        • (no location specified)
        May 8, 2023

        Breast Tumors Trial in Hangzhou (Sindilimab, Nab-paclitaxel, Lenvatinib)

        Not yet recruiting
        • Breast Neoplasms
        • Hangzhou, Zhejiang, China
          ZhejiangCH
        Nov 17, 2023

        Metastatic Triple-negative Breast Cancer Trial in Wuhan (Surufatinib, Tislelizumab)

        Not yet recruiting
        • Metastatic Triple-negative Breast Cancer
        • Wuhan, Hubei, China
          Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
        Feb 27, 2023

        Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))

        Not yet recruiting
        • Triple Negative Breast Cancer
        • +6 more
        • Implantable Microdevice (IMD)
        • Boston, Massachusetts
        • +1 more
        Mar 8, 2023